Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 248: Fighting Addiction and Expanding Access to Treatment with Sara Howe and Morgan Coyner of APNC
AI Today in 5: August 22, 2025, The Angst Episode
Daily Compliance News: August 21, 2025, The Fabricated Evidence Edition
Great Woman in Compliance: Building Strategic and Effective Risk Assessments
Daily Compliance News: August 20, 2025, The Boss is Back Edition
Gina Rubel on Leading with Integrity: Strategic Comms for Complex Times - CMO Series REPRESENTS
FCPA Compliance Report: Accountability in Times of Crisis: A Conversation with Tom Fox and Sam Silverstein
AI Today in 5: August 18, 2025, The AI Music Episode
Adventure in Compliance: The Novels - The Valley of Fear, Whistleblowers and Corporate Compliance
Sunday Book Review: August 17, 2025, The More Books from the Ethicsverse Library Edition
10 For 10: Top Compliance Stories For the Week Ending August 16, 2025
AI Today in 5: August 15, 2025, The AI as Boss Episode
Daily Compliance News: August 15, 2025, The Privilege Protected Edition
What to Do When Leadership Doesn’t Take Compliance Seriously
Daily Compliance News: August 14, 2025 The End of Dial Up Edition
Great Women in Compliance: The Mind at Work with Lynette Buebird
Daily Compliance News: August 13, 2025. The Bad App Store Ratings Edition
Daily Compliance News: August 12, 2025, The ABC Angle Edition
Daily Compliance News: August 11, 2025, The Boss Doesn’t Work Edition
Adventures in Compliance: The Novels - The Valley of Fear, Sherlock Holmes’ Investigative Techniques for Today’s Challenges
For this milestone episode, hosts Diana Shaw and Tatiana Sainati revisit the most notorious figures and scandals from the past year of Wicked Coin. From political power grabs and corporate corruption to banana barons and...more
Our Basic Academies are ideal for professionals with some compliance knowledge and experience who are ready to support, enhance and manage a comprehensive compliance program. They are taught by compliance professionals,...more
In the weeks since our first post on the Chinese investigation of GlaxoSmithKlein (GSK) for alleged “widespread bribery of doctors” to induce the prescription of GSK’s drugs, more details have emerged about the bribery...more